AR087392A1 - Combinacion antitumoral que comprende ombrabulina y cisplatino, asociada a radioterapia - Google Patents
Combinacion antitumoral que comprende ombrabulina y cisplatino, asociada a radioterapiaInfo
- Publication number
- AR087392A1 AR087392A1 ARP120102781A ARP120102781A AR087392A1 AR 087392 A1 AR087392 A1 AR 087392A1 AR P120102781 A ARP120102781 A AR P120102781A AR P120102781 A ARP120102781 A AR P120102781A AR 087392 A1 AR087392 A1 AR 087392A1
- Authority
- AR
- Argentina
- Prior art keywords
- ombrabulin
- radiotherapy
- cisplatin
- antitumoral combination
- antitumoral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una combinación farmacéutica que comprende ombrabulina o AVE8062, que puede estar en forma de base o en forma de una sal farmacéuticamente aceptable y cisplatino, para su utilización como agente antitumoral destinado a pacientes tratados asimismo por radioterapia, que sufren especialmente cánceres y aún más particularmente tumores sólidos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1157040A FR2978662A1 (fr) | 2011-08-01 | 2011-08-01 | Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie |
Publications (1)
Publication Number | Publication Date |
---|---|
AR087392A1 true AR087392A1 (es) | 2014-03-19 |
Family
ID=46832546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120102781A AR087392A1 (es) | 2011-08-01 | 2012-07-31 | Combinacion antitumoral que comprende ombrabulina y cisplatino, asociada a radioterapia |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR087392A1 (es) |
FR (1) | FR2978662A1 (es) |
TW (1) | TW201313225A (es) |
UY (1) | UY34232A (es) |
WO (1) | WO2013018017A1 (es) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4259598A (en) | 1979-12-20 | 1981-03-31 | General Electric Company | Charge transfer signal processing apparatus transversal filter |
PT1068870E (pt) * | 1998-04-03 | 2006-10-31 | Ajinomoto Kk | Agentes antitumorais |
US20020183266A1 (en) | 2001-03-15 | 2002-12-05 | Aventis Pharma, S.A. | Combination comprising combretastatin and anticancer agents |
DK1407784T3 (da) | 2001-06-25 | 2011-02-28 | Ajinomoto Kk | Antitumormidler |
FR2838437B1 (fr) | 2002-04-11 | 2004-06-04 | Aventis Pharma Sa | Procedes de preparation de combretastatines |
GB0410817D0 (en) * | 2004-05-14 | 2004-06-16 | Angiogene Pharm Ltd | Vascular damaging therapy |
FR2895258B1 (fr) | 2005-12-22 | 2008-03-21 | Aventis Pharma Sa | Combinaison comprenant de la combretastatine et des agents anticancereux |
US20090209496A1 (en) | 2008-02-15 | 2009-08-20 | David Chaplin | Methods and compositions for enhancing the efficacy of rtk inhibitors |
FR2945210B1 (fr) | 2009-05-07 | 2011-07-01 | Sanofi Aventis | Combinaison antitumorale comprenant l'ave8062 et le sorafenib |
-
2011
- 2011-08-01 FR FR1157040A patent/FR2978662A1/fr not_active Withdrawn
-
2012
- 2012-07-30 WO PCT/IB2012/053879 patent/WO2013018017A1/en active Application Filing
- 2012-07-31 AR ARP120102781A patent/AR087392A1/es not_active Application Discontinuation
- 2012-08-01 TW TW101127825A patent/TW201313225A/zh unknown
- 2012-08-01 UY UY0001034232A patent/UY34232A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW201313225A (zh) | 2013-04-01 |
FR2978662A1 (fr) | 2013-02-08 |
UY34232A (es) | 2013-02-28 |
WO2013018017A1 (en) | 2013-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017550063A1 (en) | Combination therapies for treating cancers | |
UY36307A (es) | Terapias combinadas para el tratamiento del cáncer | |
CL2015000699A1 (es) | Métodos para tratamiento de cáncer. | |
CA2909335C (en) | Fenfluramine for use in the treatment of dravet syndrome | |
MX2015011753A (es) | Metodos para tratar cancer de vegija. | |
EA201300810A1 (ru) | Противораковая терапия с использованием двойных ингибиторов киназ аврора/мек | |
CO6620019A2 (es) | Métodos de tratamiento de cander de vejiga | |
TN2013000508A1 (en) | Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer | |
MX366804B (es) | Translocaciones de la r-espondina y sus metodos de uso. | |
WO2015009726A3 (en) | Medical uses of cd38 agonists | |
MX2015014046A (es) | Combinaciones de farmacos para tratar cancer. | |
WO2013177187A3 (en) | Synergistic tumor treatment with extended-pk il-2 and therapeutic agents | |
CR20120202A (es) | Métodos y composiciones para tratar cáncer | |
UY36075A (es) | Derivados de tubulisina | |
EA201400178A1 (ru) | Лечение рака молочной железы | |
MX359210B (es) | Composición de combinación de pac-1 y tamoxifeno. | |
MX2015010791A (es) | Metodos para tratar el cancer y prevenir la resistencia a farmacos. | |
PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
MX2015014599A (es) | Terapia de combinacion que comprende un inhibidor de tor cinasa y un analogo de citidina para tracar cancer. | |
CL2013003324A1 (es) | Composicion que comprende quimioterapia con paclitaxel y carboplatino y un oligonucleotido anti-clusterina; uso de la composición para el tratamiento de un paciente humano que padece cancer de pulmón. | |
ECSP14013195A (es) | Catéter, en particular catéter permanente para el tratamiento de disfunciones y/o enfermedades de la vejiga y/o la próstata. | |
PH12016500863A1 (en) | Tetracyclic autotaxin inhibitors | |
IN2014MN01944A (es) | ||
UA117455C2 (uk) | Спосіб лікування раку легенів із застосуванням інгібітора кінази аврора | |
IL246065A0 (en) | Valiprib in combination with carboplatin for the treatment of triple negative breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |